Chengdu Bright Eye Hospital Co. Ltd. Asset Resilience Ratio

Latest as of June 2026: 1.82%

Chengdu Bright Eye Hospital Co. Ltd. asset resilience ratio. Chengdu Bright Eye Hospital Co. Ltd. (301239) has an Asset Resilience Ratio of 1.82% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Chengdu Bright Eye Hospital Co. Ltd. defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥86.90 Million
≈ $12.72 Million USD Cash + Short-term Investments

Total Assets

CN¥4.77 Billion
≈ $698.13 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Chengdu Bright Eye Hospital Co. Ltd. (2023–2025)

Asset resilience ratio of Chengdu Bright Eye Hospital Co. Ltd. from 2023 to 2025. This chart shows how Chengdu Bright Eye Hospital Co. Ltd.'s Asset Resilience Ratio has changed over time. Read how much debt does Chengdu Bright Eye Hospital Co. Ltd. carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Chengdu Bright Eye Hospital Co. Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Chengdu Bright Eye Hospital Co. Ltd.'s balance sheet.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥86.90 Million 1.82%
Total Liquid Assets CN¥86.90 Million 1.82%

Asset Resilience Insights

  • Limited Liquidity: Chengdu Bright Eye Hospital Co. Ltd. maintains only 1.82% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Chengdu Bright Eye Hospital Co. Ltd. Industry Peers by Asset Resilience Ratio

Compare Chengdu Bright Eye Hospital Co. Ltd.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Ramsay Health Care Ltd
AU:RHC
Medical Care Facilities 3.49%
Sienna Senior Living Inc
TO:SIA
Medical Care Facilities 0.09%
Mitra Keluarga Karyasehat Tbk PT
JK:MIKA
Medical Care Facilities 1.67%
GPT Healthcare Ltd
NSE:GPTHEALTH
Medical Care Facilities 9.24%
The Joint Corp
NASDAQ:JYNT
Medical Care Facilities 30126280.20%
Regis Healthcare Ltd
AU:REG
Medical Care Facilities 2.29%
Oceania Healthcare Ltd
AU:OCA
Medical Care Facilities 0.01%
Pacific Smiles Group Ltd
AU:PSQ
Medical Care Facilities 10.35%

Chengdu Bright Eye Hospital Co. Ltd. Asset Resilience Ratio by Year (2023–2025)

Chengdu Bright Eye Hospital Co. Ltd. asset resilience ratio by year from 2023 to 2025. The table below shows the annual Asset Resilience Ratio data for Chengdu Bright Eye Hospital Co. Ltd..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 1.99% CN¥90.72 Million
≈ $13.28 Million
CN¥4.56 Billion
≈ $666.65 Million
+1.55pp
2024-12-31 0.44% CN¥20.09 Million
≈ $2.94 Million
CN¥4.60 Billion
≈ $672.84 Million
-0.19pp
2023-12-31 0.63% CN¥30.10 Million
≈ $4.40 Million
CN¥4.82 Billion
≈ $704.59 Million
--
pp = percentage points

About Chengdu Bright Eye Hospital Co. Ltd.

SHE:301239 China Medical Care Facilities
Market Cap
$779.86 Million
CN¥5.33 Billion CNY
Market Cap Rank
#9630 Global
#2392 in China
Share Price
CN¥35.62
Change (1 day)
-0.20%
52-Week Range
CN¥29.09 - CN¥46.83
All Time High
CN¥136.98
About

Bright Eye Hospital Group Co., Ltd., together with its subsidiaries, operates ophthalmic medical institutions in China. The company offers ophthalmic diagnostic and treatment services, including refractive surgery, medical optometry and glasses fitting, cataract surgery, glaucoma treatment, strabismus and amblyopia, pediatric ophthalmology, fundus diseases treatment, oculoplastic surgery, lacrima… Read more